Page results
-
Simon Porter joined UCLH as a non-executive director on 1 April 2020. He is a chartered accountant whose executive career at the London office of Ernst & Young ranged across audit, corporate finance and risk management.
-
UCLH is to trial the COVID-19 vaccine developed by University of Oxford in healthy staff volunteers.
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
-
Brain surgery survivor’s labour of love to bring Chelsea garden to hospital
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
-
The research team said the placenta acted as a barrier to transmission.
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
File results
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0386 - Stonewall funding for 2022/23-2023/24
-
FOI/2024/0391 - Hospital admissions due to psychedelics consumption
-
FOI/2024/0404 - Senior HR/ Workforce staff contact details
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0445 - Framework agency spend for locum doctors for February to March 2024
-
FOI/2024/0535 - Agency spend, providers and department contacts for locums by specialities and sites
-
FOI/2024/0444 - Protocols for titanium/ titanium alloy clips to repair ruptured brain aneurysms
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage